Researchers interested can capitalize on methods mentioned[59] in combination with findings in the current research, namely, discovering whether the abovementioned hub genes, especially KRAS and MAP1, would be appropriate for blood-based detection assays in HCC. Here, KRAS is linked to hepatocellular carcinoma.